Seaport Therapeutics, Inc.

NasdaqGS:SPTX Stock Report

Market Cap: US$1.3b

Seaport Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

NasdaqGS:SPTX Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
22 Jun 26BuyUS$235,768Robert HombachIndividual13,000US$18.14
04 May 26BuyUS$19,800,000ARCH Venture Fund XII, L.P.Company1,100,000US$18.00
01 May 26BuyUS$19,800,000ARCH Venture Fund XII, L.P.Company1,100,000US$18.00

Insider Trading Volume

Insider Buying: SPTX insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of SPTX?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders2,449,5954.33%
VC/PE Firms15,961,40428.2%
Public Companies16,685,01329.5%
Institutions21,476,63138%

Dilution of Shares: SPTX only recently listed within the past 12 months


Top Shareholders

Top 25 shareholders own 101.35% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
31.2%
PureTech Health plc
16,685,013US$405.6m0%no data
11.8%
Arch Venture Partners, L.P.
6,294,951US$153.0m0%7.67%
11.4%
General Atlantic Service Company, L.P.
6,101,582US$148.3m0%3.27%
6.66%
Sofinnova Investments, Inc.
3,564,871US$86.7m0%4.42%
3.85%
Third Rock Ventures, LLC
2,061,222US$50.1m0%4.4%
3.69%
Canada Pension Plan Investment Board
1,975,791US$48.0m0%0.02%
3.33%
JP Morgan Asset Management
1,785,104US$43.4m0%no data
3.32%
Foresite Capital Management, LLC
1,779,521US$43.3m0%2.87%
2.44%
T. Rowe Price Group, Inc.
1,308,604US$31.8m0%no data
2.23%
The Goldman Sachs Group, Inc.
1,194,858US$29.0m0%0.01%
2.23%
Daphne Zohar
1,194,001US$29.0m0%no data
2.21%
FMR LLC
1,185,100US$28.8m0%no data
2.05%
Bellevue Asset Management AG
1,100,000US$26.7m0%0.43%
2.05%
Artal Group S.A.
1,095,316US$26.6m0%0.38%
2.02%
Jennison Associates LLC
1,079,669US$26.2m0%0.01%
1.84%
Goldman Sachs Asset Management, L.P.
983,784US$23.9m0%no data
1.61%
Steven Paul
863,031US$21.0m0%no data
1.31%
RA Capital Management, L.P.
700,000US$17.0m0%0.14%
1.28%
Vanguard Capital Management, LLC
686,989US$16.7m0%no data
1.1%
Woodline Partners LP
586,345US$14.3m0%0.04%
0.93%
Perceptive Advisors LLC
500,000US$12.2m0%0.18%
0.93%
Braidwell LP
500,000US$12.2m0%0.41%
0.77%
Principal Global Investors, LLC
414,672US$10.1m0%no data
0.58%
Aberdeen Group Plc
310,355US$7.5m0%no data
0.57%
Eric Elenko
302,480US$7.4m0%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/08/24 15:33
End of Day Share Price 2026/08/21 00:00
Earnings2026/06/30
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Seaport Therapeutics, Inc. is covered by 7 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Yigal NochomovitzCitigroup Inc
Salveen RichterGoldman Sachs
Raghuram SelvarajuH.C. Wainwright & Co.